Imidazo-substituted compounds as p38 kinase inhibitors

摘要

The present invention discloses compounds corresponding to formula I: wherein A, Z, Z¹, Y, R¹ and R² are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.